Who will take informed consent? {26a}
pulmonary TB
Information about the trial is provided by study doctors/nurses at the trial site, who need to be delegated to perform these tasks. Participants will be invited to be screened for inclusion in the trial if they are suspected to have pulmonary TB or have an established diagnosis by smear microscopy, GeneXpert or chest X-ray done within the government or private health sector. The investigator or a person designated by the investigator will inform the participants or the participant’s legally acceptable representative in detail. After signing the informed consent form, participants are screened for inclusion and exclusion criteria, and, if eligible, enrolled in the study and randomized to one of the treatment arms.